Synthesis of 4-Hydroxy-2-pyridinone Derivatives and Evaluation of Their Antioxidant/Anticancer Activities

被引:16
作者
Hamama, Wafaa S. [1 ]
Ghaith, Eslam A. [1 ]
Ibrahim, Mona E. [1 ]
Sawamura, Masaya [2 ]
Zoorob, Hanafi H. [1 ]
机构
[1] Mansoura Univ, Fac Sci, Dept Chem, Mansoura 35516, Egypt
[2] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido 0010021, Japan
来源
CHEMISTRYSELECT | 2021年 / 6卷 / 07期
关键词
Antioxidants; Cytotoxic Activity; Dehydroacetic acid; Mechanisms; Molecular Modeling; Pyridinone; Reactions;
D O I
10.1002/slct.202004682
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A simple approach was applied for the regioselective synthesis of various pyridine-2-one derivatives or annulated pyridine as novel heterocyclic systems from the reaction of dehydroacetic acid (DHA) with mono- or bidentate nucleophile as with benzylamine and/or phenylenediamines in dichloromethane followed by transformation with different halo-compounds in refluxing 1,4-dioxane has been achieved in moderate to excellent yields (48-93 %). In addition, DFT studies of the key synthesized compounds were carried out for confirmed proposed mechanisms. The newly synthesized compounds were screened for their in-vitro inhibition activities against mammary gland breast cancer (MCF-7) and human prostate cancer (PC-3) using the MTT colorimetric method. Also, the target synthesized compounds were evaluated as antioxidant agents.
引用
收藏
页码:1430 / 1439
页数:10
相关论文
共 42 条
  • [1] Al-Sehemi AG, 2014, INDIAN J CHEM B, V53, P1115
  • [2] Anam O., 2017, THERAP ADV GASTROENT, V10, P877
  • [3] Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells
    Androustsopoulos, Vasilis P.
    Spandidos, Demetrios A.
    [J]. ONCOLOGY REPORTS, 2018, 39 (02) : 519 - 524
  • [4] Development of huperzine A and B for treatment of Alzheimer's disease
    Bai, Donglu
    [J]. PURE AND APPLIED CHEMISTRY, 2007, 79 (04) : 469 - 479
  • [5] Synthesis and antibacterial activities of enamine derivatives of dehydroacetic acid
    Baldwin, Alex G.
    Bevan, Jonathan
    Brough, David
    Ledder, Ruth
    Freeman, Sally
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (03) : 884 - 889
  • [6] Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents
    Bekhit, AA
    Baraka, AM
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (12) : 1405 - 1413
  • [7] TTI-237:: A novel microtubule-active compound with in vivo antitumor activity
    Beyer, Carl F.
    Zhang, Nan
    Hernandez, Richard
    Vitale, Danielle
    Lucas, Judy
    Nguyen, Thai
    Discafani, Carolyn
    Ayral-Kaloustian, Semiramis
    Gibbons, James J.
    [J]. CANCER RESEARCH, 2008, 68 (07) : 2292 - 2300
  • [8] Synthesis and in vitro anti-proliferative effects of 3-(hetero)aryl substituted 3-[(prop-2-ynyloxy)(thiophen-2-yl)methyl]pyridine derivatives on various cancer cell lines
    Chamakura, Upendar Reddy
    Sailaja, E.
    Dulla, Balakrishna
    Kalle, Arunasree M.
    Bhavani, S.
    Rambabu, D.
    Kapavarapu, Ravikumar
    Rao, M. V. Basaveswara
    Pal, Manojit
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (05) : 1366 - 1372
  • [9] Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants
    Chen, Wenteng
    Guo, Xiao
    Zhang, Can
    Ke, Di
    Zhang, Guolin
    Yu, Yongping
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
  • [10] Molecular and crystal structures of N,N′-propylene- and N,N′-phenylene-diylbis [3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione]
    Cindric, M
    Novak, TK
    Uzarevic, K
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2005, 750 (1-3) : 135 - 141